1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
Article
You have full text access to this OnlineOpen article
Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation
Article first published online: 8 DEC 2009
DOI: 10.1002/pro.301
Copyright © 2009 The Protein Society
Additional Information
How to Cite
Lai, T. S., Davies, C. and Greenberg, C. S. (2010), Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Science, 19: 229–235. doi: 10.1002/pro.301
Publication History
- Issue published online: 21 JAN 2010
- Article first published online: 8 DEC 2009
- Accepted manuscript online: 8 DEC 2009 12:00AM EST
- Manuscript Accepted: 27 NOV 2009
- Manuscript Revised: 29 SEP 2009
- Manuscript Received: 12 AUG 2009
Funded by
- NIH. Grant Numbers: HL072184, NS050541
References
- 1( 1983) Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Advam Enzymol Rel Areas Mol Biol 54: 1–56.
- 2, ( 2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Rev 4: 140–156.
- 3, , ( 1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5: 3071–3077.
- 4, , ( 2008) Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol 585: 464–472.
- 5, , , , , , , , , , ( 2002) ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9: 873–880.
- 6, ( 2005) Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms. J Neurochem 92: 83–92.Direct Link:
- 7, , , , , , , , , , , ( 2002) Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci 22: 8942–8950.
- 8, , , , ( 2005) Mechanism for the inhibition of transglutaminase 2 by cystamine. Biochem Pharmacol 69: 961–970.
- 9, , , , , , , ( 2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8: 143–149.
- 10, , , , ( 2004) Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem 88: 1253–1260.Direct Link:
- 11, , , , , ( 2008) Tissue transglutaminase modulates alpha-synuclein oligomerization. Protein Sci 17: 1395–1402.Direct Link:
- 12, , , , , ( 2005) Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking. Biochemistry 44: 2072–2079.
- 13, , ( 1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73: 1871–1880.
- 14, , , , , , , , ( 2008) Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol 15: 969–978.
- 15, , , ( 2003) Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem Biol 10: 225–231.
- 16, ( 1992) Post-translational chemical modification(s) of proteins. Int J Biochem 24: 19–28.
- 17, , , ( 1995) Surface lysine residues modulate the collisional transfer of fatty acid from adipocyte fatty acid binding protein to membranes. Biochemistry 34: 11840–11845.
- 18, ( 2003) Regulating the regulators: Lysine modifications make their mark. Cell 112: 11–17.
- 19, , , ( 1992) A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Analyt Biochem 205: 166–171.
- 20, , , ( 2004) Mapping of factor XIII solvent accessibility as a function of activation state using chemical modification methods. Biochemistry 43: 9755–9765.
- 21, , , , ( 2004) Probing rhodopsin-transducin interactions by surface modification and mass spectrometry. Biochemistry 43: 11153–11162.
- 22, ( 1986) Acetylation of antithrombin III by aspirin. Semin Thromb Hemost 12: 213–215.
- 23, , ( 1999) Acetylation of human hemoglobin by methyl acetylphosphate. Evidence of broad regio-selectivity revealed by NMR studies. J Biol Chem 274: 26629–26632.
- 24, , , ( 1999) NMR study of the sites of human hemoglobin acetylated by aspirin. Biochim Biophys Acta 1432: 333–349.
- 25, , , , ( 2001) Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. Ann NY Acad Sci 936: 531–535.
- 26( 1976) Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett 66: 173–175.
- 27, ( 1993) Hydrolysis and stability of acetylsalicylic acid in stearylamine-containing liposomes. J Pharm Pharmacol 45: 496–499.
- 28, ( 2008) Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases. CNS Neurol Disord Drug Targets 7: 370–375.
- 29, ( 2007) Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharm Therap 115: 232–245.
- 30, , , , ( 1985) Hydrophobicity of amino acid residues in globular proteins. Science 229: 834–838.
- 31, ( 1994) Protein footprinting by the combined use of reversible and irreversible lysine modifications. Proc Natl Acad Sci USA 91: 11904–11908.
- 32, ( 2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31: 449–461.
- 33
- 34, , ( 2002) Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci USA 99: 2743–2747.
- 35( 1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 24: 946–950.Direct Link:
- 36, ( 1994) Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Cryst D 50: 869–873.Direct Link:
- 37, , , ( 2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5: e327.
- 38, ( 2008) Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease. Curr Pharm Des 14: 1428–1434.
- 39, , , ( 1972) Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 61: 379–385.Direct Link:
- 40( 2008) An aspirin a day for Alzheimer's disease? Lancet Neurol 7: 20–21.
- 41, , , , , , , , ( 2004) Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice. Neurobiol Dis 17: 319–325.
- 42, , , , ( 1998) Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg- GTP and Mg-ATP. J Biol Chem 273: 1776–1781.
- 43, , , ( 1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551–3567.Direct Link: